{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:08Z","timestamp":1786982108081,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11864-018-0567-4","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T01:57:27Z","timestamp":1534298247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prognostic Factors of Extramammary Paget\u2019s Disease"],"prefix":"10.1007","volume":"19","author":[{"given":"Naohito","family":"Hatta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,15]]},"reference":[{"key":"567_CR1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.det.2010.08.002","volume":"28","author":"C Lam","year":"2010","unstructured":"Lam C, Funaro D. Extramammary Paget\u2019s disease: summary of current knowledge. Dermatol Clin. 2010;28:807\u201326.","journal-title":"Dermatol Clin"},{"key":"567_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1072-7515(02)01619-8","volume":"196","author":"JP Pierie","year":"2003","unstructured":"Pierie JP, Choudry U, Muzikansky A, Finkelstein DM, Ott MJ. Prognosis and management of extramammary Paget\u2019s disease and the association with secondary malignancies. J Am Coll Surg. 2003;196:45\u201350.","journal-title":"J Am Coll Surg"},{"key":"567_CR3","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Ohara K, Fujisawa Y, Yoshino K, Kiyohara Y, Kadono T, Murata Y, et al. A proposal for a TNM staging system for extramammary Paget disease: retrospective analysis of 301 patients with invasive primary tumors. J Dermatol Sci. 2016;83:234\u20139. Important proposal of TNM staging system.","DOI":"10.1016\/j.jdermsci.2016.06.004"},{"key":"567_CR4","first-page":"313","volume":"158","author":"N Hatta","year":"2008","unstructured":"Hatta N, Yamada M, Hirano T, Fujimoto A, Morita R. Extramammary Paget\u2019s disease: treatment, prognostic factors and outcome in 76 patients. Br J Dermatol. 2008;158:313\u20138.","journal-title":"Br J Dermatol"},{"key":"567_CR5","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1111\/j.1524-4725.2012.02584.x","volume":"38","author":"Y Ito","year":"2012","unstructured":"Ito Y, Igawa S, Ohishi Y, Uehara J, Yamamoto AI, Iizuka H. Prognostic indicators in 35 patients with extramammary Paget\u2019s disease. Dermatol Surg. 2012;38:1938\u201344.","journal-title":"Dermatol Surg"},{"key":"567_CR6","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Ito T, Kaku Y, Nagae K, Nakano-Nakamura M, Nakahara T, Oda Y, et al. Tumor thickness as a prognostic factor in extramammary Paget\u2019s disease. J Dermatol. 2015;42:269\u201375. Important trial on prognostic factor in EMPD.","DOI":"10.1111\/1346-8138.12764"},{"key":"567_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.ejso.2006.11.028","volume":"33","author":"S Siesling","year":"2007","unstructured":"Siesling S, Elferink MA, van Dijck JA, Pierie JP, Blokx WA. Epidemiology and treatment of extramammary Paget disease in the Netherlands. Eur J Surg Oncol. 2007;33:951\u20135.","journal-title":"Eur J Surg Oncol"},{"key":"567_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ygyno.2012.01.032","volume":"125","author":"A Karam","year":"2012","unstructured":"Karam A, Dorigo O. Treatment outcomes in a large cohort of patients with invasive Extramammary Paget\u2019s disease. Gynecol Oncol. 2012;125:346\u201351.","journal-title":"Gynecol Oncol"},{"key":"567_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-4632.2010.04661.x","volume":"50","author":"SJ Lee","year":"2011","unstructured":"Lee SJ, Choe YS, Jung HD, Ahn SK, Cha YC, Cho KH, et al. A multicenter study on extramammary Paget\u2019s disease in Korea. Int J Dermatol. 2011;50:508\u201315.","journal-title":"Int J Dermatol"},{"key":"567_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/bjd.12851","volume":"171","author":"PS Cheng","year":"2014","unstructured":"Cheng PS, Lu CL, Cheng CL, Lai FJ. Significant male predisposition in extramammary Paget disease: a nationwide population-based study in Taiwan. Br J Dermatol. 2014;171:191\u20133.","journal-title":"Br J Dermatol"},{"key":"567_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12885-018-4257-1","volume":"18","author":"H Yao","year":"2018","unstructured":"\u2022 Yao H, Xie M, Fu S, Guo J, Peng Y, Cai Z, et al. Survival analysis of patients with invasive extramammary Paget disease: implications of anatomic sites. BMC Cancer. 2018;18:403. Survival analysis on large number of Patients.","journal-title":"BMC Cancer"},{"key":"567_CR12","doi-asserted-by":"crossref","unstructured":"\u2022 Iacoponi S, Zalewski K, Fruscio R, Diaz-De la Noval B, De Iaco P, Ceccaroni M, et al. Prognostic factors for recurrence and survival among patients with invasive vulvar Paget disease included in the VULCAN study. Int J Gynaecol Obstet. 2016;133:76\u20139. Multicenter study on prognostic factors.","DOI":"10.1016\/j.ijgo.2015.08.018"},{"key":"567_CR13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s10350-004-6618-x","volume":"46","author":"MD McCarter","year":"2003","unstructured":"McCarter MD, Quan SH, Busam K, Paty PP, Wong D, Guillem JG. Long-term outcome of perianal Paget\u2019s disease. Dis Colon Rectum. 2003;46:612\u20136.","journal-title":"Dis Colon Rectum"},{"key":"567_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/dsu.12019","volume":"39","author":"B Mengjun","year":"2013","unstructured":"Mengjun B, Zheng-Qiang W, Tasleem MM. Extramammary Paget\u2019s disease of the perianal region: a review of the literature emphasizing management. Dermatol Surg. 2013;39:69\u201375.","journal-title":"Dermatol Surg"},{"key":"567_CR15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0190-9622(85)70254-X","volume":"13","author":"JJ Chanda","year":"1985","unstructured":"Chanda JJ. Extramammary Paget\u2019s disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol. 1985;13:1009\u201314.","journal-title":"J Am Acad Dermatol"},{"key":"567_CR16","first-page":"21","volume":"29","author":"A Tsutsumida","year":"2003","unstructured":"Tsutsumida A, Yamamoto Y, Minakawa H, Yoshida T, Kokubu I, Sugihara T. Indications for lymph node dissection in the treatment of extramammary Paget\u2019s disease. Dermatol Surg. 2003;29:21\u20134.","journal-title":"Dermatol Surg"},{"key":"567_CR17","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00384-008-0499-8","volume":"23","author":"SN Yoon","year":"2008","unstructured":"Yoon SN, Park IJ, Kim HC, Yu CS, Lee MW, Koh JK, et al. Extramammary Paget\u2019s disease in Korea: its association with gastrointestinal neoplasms. Int J Color Dis. 2008;23:1125\u201330.","journal-title":"Int J Color Dis"},{"key":"567_CR18","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1097\/PAS.0000000000000709","volume":"40","author":"Z Kang","year":"2016","unstructured":"Kang Z, Xu F, Zhu Y, Fu P, Zhang QA, Hu T, et al. Genetic analysis of mismatch repair genes alterations in extramammary Paget disease. Am J Surg Pathol. 2016;40:1517\u201325.","journal-title":"Am J Surg Pathol"},{"key":"567_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00000478-199802000-00004","volume":"22","author":"JR Goldblum","year":"1998","unstructured":"Goldblum JR, Hart WR. Perianal Paget\u2019s disease: a histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma. Am J Surg Pathol. 1998;22:170\u20139.","journal-title":"Am J Surg Pathol"},{"key":"567_CR20","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1365-2133.2005.06798.x","volume":"153","author":"MC Nisi De","year":"2005","unstructured":"De Nisi MC, D'Amuri A, Toscano M, Lalinga AV, Pirtoli L, Miracco C. Usefulness of CDX2 in the diagnosis of extramammary Paget disease associated with malignancies of intestinal type. Br J Dermatol. 2005;153:677\u20139.","journal-title":"Br J Dermatol"},{"key":"567_CR21","doi-asserted-by":"crossref","unstructured":"van der Linden M, Schuurman MS, Bulten J, Massuger L, IntHout J, van der Aa MA, et al. Stop routine screening for associated malignancies in cutaneous non-invasive vulvar Paget disease? Br J Dermatol. 2018.","DOI":"10.1111\/bjd.17283"},{"key":"567_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0090-8258(90)90016-E","volume":"38","author":"GA Feuer","year":"1990","unstructured":"Feuer GA, Shevchuk M, Calanog A. Vulvar Paget\u2019s disease: the need to exclude an invasive lesion. Gynecol Oncol. 1990;38:81\u20139.","journal-title":"Gynecol Oncol"},{"key":"567_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/ced.12690","volume":"40","author":"JM Cohen","year":"2015","unstructured":"Cohen JM, Granter SR, Werchniak AE. Risk stratification in extramammary Paget disease. Clin Exp Dermatol. 2015;40:473\u20138.","journal-title":"Clin Exp Dermatol"},{"key":"567_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1006\/gyno.1995.1138","volume":"57","author":"BA Fine","year":"1995","unstructured":"Fine BA, Fowler LJ, Valente PT, Gaudet T. Minimally invasive Paget\u2019s disease of the vulva with extensive lymph node metastases. Gynecol Oncol. 1995;57:262\u20135.","journal-title":"Gynecol Oncol"},{"key":"567_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.humpath.2015.09.005","volume":"47","author":"B Shu","year":"2016","unstructured":"Shu B, Shen XX, Chen P, Fang XZ, Guo YL, Kong YY. Primary invasive extramammary Paget disease on penoscrotum: a clinicopathological analysis of 41 cases. Hum Pathol. 2016;47:70\u20137.","journal-title":"Hum Pathol"},{"key":"567_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2133.1984.tb07469.x","volume":"110","author":"M Oji","year":"1984","unstructured":"Oji M, Furue M, Tamaki K. Serum carcinoembryonic antigen level in Paget\u2019s disease. Br J Dermatol. 1984;110:211\u20133.","journal-title":"Br J Dermatol"},{"key":"567_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1365-2133.2009.09203.x","volume":"161","author":"Y Zhu","year":"2009","unstructured":"Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, et al. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget\u2019s disease. Br J Dermatol. 2009;161:577\u201382.","journal-title":"Br J Dermatol"},{"key":"567_CR28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/1346-8138.13760","volume":"44","author":"J Kato","year":"2017","unstructured":"Kato J, Sumikawa Y, Hida T, Kamiya T, Horimoto K, Kamiya S, et al. Serum cytokeratin 19 fragment 21-1 is a useful tumor marker for the assessment of extramammary Paget\u2019s disease. J Dermatol. 2017;44:666\u201370.","journal-title":"J Dermatol"},{"key":"567_CR29","first-page":"91","volume":"32","author":"N Inoguchi","year":"2007","unstructured":"Inoguchi N, Matsumura Y, Kanazawa N, Morita K, Tachibana T, Sakurai T, et al. Expression of prostate-specific antigen and androgen receptor in extramammary Paget\u2019s disease and carcinoma. Clin Exp Dermatol. 2007;32:91\u20134.","journal-title":"Clin Exp Dermatol"},{"key":"567_CR30","first-page":"13233","volume":"8","author":"Z Kang","year":"2015","unstructured":"Kang Z, Zhang Q, Zhang Q, Li X, Hu T, Xu X, et al. Clinical and pathological characteristics of extramammary Paget\u2019s disease: report of 246 Chinese male patients. Int J Clin Exp Pathol. 2015;8:13233\u201340.","journal-title":"Int J Clin Exp Pathol"},{"key":"567_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/ajcp\/108.1.6","volume":"108","author":"OE Battles","year":"1997","unstructured":"Battles OE, Page DL, Johnson JE. Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget\u2019s disease. Am J Clin Pathol. 1997;108:6\u201312.","journal-title":"Am J Clin Pathol"},{"key":"567_CR32","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1097\/00000478-199710000-00008","volume":"21","author":"JR Goldblum","year":"1997","unstructured":"Goldblum JR, Hart WR. Vulvar Paget\u2019s disease: a clinicopathologic and immunohistochemical study of 19 cases. Am J Surg Pathol. 1997;21:1178\u201387.","journal-title":"Am J Surg Pathol"},{"key":"567_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1046\/j.1365-2133.2000.03291.x","volume":"142","author":"T Ohnishi","year":"2000","unstructured":"Ohnishi T, Watanabe S. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget\u2019s disease. Br J Dermatol. 2000;142:243\u20137.","journal-title":"Br J Dermatol"},{"key":"567_CR34","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1046\/j.1440-1827.2002.01364.x","volume":"52","author":"N Yoshii","year":"2002","unstructured":"Yoshii N, Kitajima S, Yonezawa S, Matsukita S, Setoyama M, Kanzaki T. Expression of mucin core proteins in extramammary Paget\u2019s disease. Pathol Int. 2002;52:390\u20139.","journal-title":"Pathol Int"},{"key":"567_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2559.2007.02633.x","volume":"50","author":"B Liegl","year":"2007","unstructured":"Liegl B, Leibl S, Gogg-Kamerer M, Tessaro B, Horn LC, Moinfar F. Mammary and extramammary Paget\u2019s disease: an immunohistochemical study of 83 cases. Histopathology. 2007;50:439\u201347.","journal-title":"Histopathology"},{"key":"567_CR36","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/jdv.12156","volume":"28","author":"H Hata","year":"2014","unstructured":"Hata H, Abe R, Hoshina D, Saito N, Homma E, Aoyagi S, et al. MUC5AC expression correlates with invasiveness and progression of extramammary Paget\u2019s disease. J Eur Acad Dermatol Venereol. 2014;28:727\u201332.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"567_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fonc.2018.00038","volume":"8","author":"K Fukuda","year":"2018","unstructured":"\u2022 Fukuda K, Funakoshi T. Metastatic extramammary Paget\u2019s disease: pathogenesis and novel therapeutic approach. Front Oncol. 2018;8:38. Excellent review on treatment of metastatic EMPD.","journal-title":"Front Oncol"},{"key":"567_CR38","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1046\/j.1523-1747.1999.00634.x","volume":"113","author":"M Takata","year":"1999","unstructured":"Takata M, Fujimoto A, Aoki H, Hatta N, Ooi A, Takehara K. erbB-2 overexpression but no activation of beta-Catenin gene in extramammary Paget\u2019s disease. J Invest Dermatol. 1999;113:258\u201362.","journal-title":"J Invest Dermatol"},{"key":"567_CR39","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/bjd.12249","volume":"168","author":"R Tanaka","year":"2013","unstructured":"Tanaka R, Sasajima Y, Tsuda H, Namikawa K, Tsutsumida A, Otsuka F, et al. Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease. Br J Dermatol. 2013;168:1259\u201366.","journal-title":"Br J Dermatol"},{"key":"567_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jdermsci.2007.12.002","volume":"50","author":"S Aoyagi","year":"2008","unstructured":"Aoyagi S, Akiyama M, Shimizu H. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget\u2019s disease. J Dermatol Sci. 2008;50:177\u201384.","journal-title":"J Dermatol Sci"},{"key":"567_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2133.2006.07366.x","volume":"155","author":"H Liu","year":"2006","unstructured":"Liu H, Moroi Y, Yasumoto S, Kokuba H, Imafuku S, Koga T, et al. Expression of insulin-like growth factor-1 receptor, p-AKT and p-ERK1\/2 protein in extramammary Paget\u2019s disease. Br J Dermatol. 2006;155:586\u201391.","journal-title":"Br J Dermatol"},{"key":"567_CR42","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1365-2133.2005.06951.x","volume":"154","author":"HJ Liu","year":"2006","unstructured":"Liu HJ, Moroi Y, Masuda T, Yasumoto S, Kokuba H, Imafuku S, et al. Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease. Br J Dermatol. 2006;154:926\u201332.","journal-title":"Br J Dermatol"},{"key":"567_CR43","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1365-2230.2008.02851.x","volume":"33","author":"S Chen","year":"2008","unstructured":"Chen S, Moroi Y, Urabe K, Takeuchi S, Kido M, Hayashida S, et al. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease. Clin Exp Dermatol. 2008;33:634\u201340.","journal-title":"Clin Exp Dermatol"},{"key":"567_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00403-008-0829-2","volume":"300","author":"SY Chen","year":"2008","unstructured":"Chen SY, Moroi Y, Urabe K, Takeuchi S, Kido M, Hayashida S, et al. Concordant overexpression of p-FAK and p-ERK1\/2 in extramammary Paget\u2019s disease. Arch Dermatol Res. 2008;300:195\u2013201.","journal-title":"Arch Dermatol Res"},{"key":"567_CR45","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/j.1600-0560.2010.01563.x","volume":"37","author":"Y Qian","year":"2010","unstructured":"Qian Y, Takeuchi S, Chen SJ, Dugu L, Tsuji G, Xie L, et al. Nerve growth factor, brain-derived neurotrophic factor and their high-affinity receptors are overexpressed in extramammary Paget\u2019s disease. J Cutan Pathol. 2010;37:1150\u20134.","journal-title":"J Cutan Pathol"},{"key":"567_CR46","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1600-0560.2012.01973.x","volume":"39","author":"Y Qian","year":"2012","unstructured":"Qian Y, Zhang N, Chen S, Chu S, Feng A, Liu H. PI3K, Rac1 and pPAK1 are overexpressed in extramammary Paget\u2019s disease. J Cutan Pathol. 2012;39:1010\u20135.","journal-title":"J Cutan Pathol"},{"key":"567_CR47","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/modpathol.2012.65","volume":"25","author":"Z Kang","year":"2012","unstructured":"Kang Z, Xu F, Zhang QA, Lin J, Wu Z, Zhang X, et al. Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget\u2019s disease. Mod Pathol. 2012;25:1160\u20138.","journal-title":"Mod Pathol"},{"key":"567_CR48","doi-asserted-by":"publisher","first-page":"e20769","DOI":"10.1371\/journal.pone.0020769","volume":"6","author":"R Duttagupta","year":"2011","unstructured":"Duttagupta R, Jiang R, Gollub J, Getts RC, Jones KW. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One. 2011;6:e20769.","journal-title":"PLoS One"},{"key":"567_CR49","doi-asserted-by":"crossref","unstructured":"Guo H, Qi RQ, Lv YN, Wang HX, Hong YX, Zheng S, et al. miR-31 is distinctively overexpressed in primary male extramammary Paget\u2019s disease. Oncotarget. 2016;7:24559\u201363.","DOI":"10.18632\/oncotarget.8230"},{"key":"567_CR50","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/00003072-200212000-00021","volume":"27","author":"G Kudo","year":"2002","unstructured":"Kudo G, Toyama H, Hasegawa K, Kuroda M, Hattori H, Ishiguro M, et al. Sentinel lymph node navigation surgery in Paget\u2019s disease of the vulva. Clin Nucl Med. 2002;27:909\u201310.","journal-title":"Clin Nucl Med"},{"key":"567_CR51","first-page":"1329","volume":"30","author":"N Hatta","year":"2004","unstructured":"Hatta N, Morita R, Yamada M, Echigo T, Hirano T, Takehara K, et al. Sentinel lymph node biopsy in patients with extramammary Paget\u2019s disease. Dermatol Surg. 2004;30:1329\u201334.","journal-title":"Dermatol Surg"},{"key":"567_CR52","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ygyno.2004.09.008","volume":"95","author":"T Ewing","year":"2004","unstructured":"Ewing T, Sawicki J, Ciaravino G, Rumore GJ. Microinvasive Paget\u2019s disease. Gynecol Oncol. 2004;95:755\u20138.","journal-title":"Gynecol Oncol"},{"key":"567_CR53","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/j.1365-2133.2012.11017.x","volume":"167","author":"Y Nakamura","year":"2012","unstructured":"Nakamura Y, Fujisawa Y, Ishikawa M, Nakamura Y, Ishitsuka Y, Maruyama H, et al. Usefulness of sentinel lymph node biopsy for extramammary Paget disease. Br J Dermatol. 2012;167:954\u20136.","journal-title":"Br J Dermatol"},{"key":"567_CR54","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1684\/ejd.2016.2744","volume":"26","author":"D Ogata","year":"2016","unstructured":"Ogata D, Kiyohara Y, Yoshikawa S, Tsuchida T. Usefulness of sentinel lymph node biopsy for prognostic prediction in extramammary Paget\u2019s disease. Eur J Dermatol. 2016;26:254\u20139.","journal-title":"Eur J Dermatol"},{"key":"567_CR55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jdermsci.2015.03.014","volume":"79","author":"Y Fujisawa","year":"2015","unstructured":"\u2022 Fujisawa Y, Yoshino K, Kiyohara Y, Kadono T, Murata Y, Uhara H, et al. The role of sentinel lymph node biopsy in the management of invasive extramammary Paget\u2019s disease: multi-center, retrospective study of 151 patients. J Dermatol Sci. 2015;79:38\u201342. Multicenter trial on sentinel lymph node biopsy in invasive EMPD.","journal-title":"J Dermatol Sci"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-018-0567-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-018-0567-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-018-0567-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T15:08:04Z","timestamp":1604761684000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-018-0567-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,15]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1007\/s11864-018-0567-4","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,15]]},"assertion":[{"value":"15 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"47"}}